(Total Views: 47)
Posted On: 07/15/2024 11:44:45 AM
Post# of 9
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Hemostemix ($HEM) utilizes its technology platform to create autologous cell therapies, with a 52-week range of $0.175 to $0.035, showing significant potential for growth in biotechnology.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)